Publication / Source: Bioanalysis 2(2)
Authors: Ackermann LB
The 5th annual Applied Pharmaceutical Analysis (APA) Conference recently convened in Boston, affording a unique opportunity for analytical scientists and pharmaceutical opinion leaders to exchange ideas on subjects related to drug disposition. The theme for this year’s meeting, The Role of Bioanalysis and Absorption, Distribution, Metabolism, and Excretion in Translational Medicine, was evident throughout the sessions. Consistent with past meetings, the sessions were grouped into three workshops representing different areas of focus: regulated bioanalysis, biotransformation and discovery. A total of 68 talks were presented at APA 2009, along with nine posters. While MS was the main analytical tool represented, several ligand-binding applications were also presented, consistent with the current industry trend towards protein biomarkers and biotherapeutics. Overall, the meeting attracted 290 attendees, which represents an 8% increase from 2008. The affiliation of attendees was as follows: pharmaceutical and biotechnology (61%), contract research organization (24%), vendor (12%) and academics or government (3%).